KVK Tech Gift to Support Stanford's Department of Bariatric and Minimally Invasive Surgery

News provided by

Aug 08, 2017, 09:36 ET

NEWTOWN, Pa., Aug. 8, 2017 /PRNewswire/ -- KVK Tech, Inc. is pleased to report that it has donated $65,000 to Leland Stanford Junior University to further advocacy and scholarship for the care of obese patients.

More than one-third of adults in the U.S. have obesity, and overweight and obesity-related conditions including heart disease, stroke, type 2 diabetes, and certain types of cancer are the second leading cause of preventable death in the U.S., following tobacco. Obesity is a chronic metabolic disease that must be managed appropriately to reduce the risk of serious health conditions.

"We are happy to support such a respected institution for clinical research that will improve surgical outcomes and advance the practice of weight-loss medicine", states Anthony Tabasso, President and Chief Executive Officer of KVK Tech. "KVK is the leading manufacturer of FDA-approved medicines for the obesity patient in the U.S. and committed to advancing weight-management strategies through research discoveries to provide an evidence-based understanding of obesity."

The obesity epidemic is a complex problem that requires a multifaceted approach to the appropriate care and management of patients. People who are overweight or obese have a much greater risk of developing serious conditions that will increase overall healthcare costs.

"Anytime we can support research on the causes and consequences of overweight and obesity that may result in potential prevention and treatment strategies, it's a win for many stakeholders," added Mr. Tabasso.

About KVK Tech

KVK is a leader in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. Founded in 2004, KVK takes pride in its ability to advance medical care and offer low-cost alternatives in response to today's healthcare challenges. KVK manufactures and distributes Lomaira™ (phentermine hydrochloride USP) 8 mg tablets CIV. All of KVK's products are made in the U.S.A. in a state-of-the-art facility in Newtown, PA. www.kvktech.com. For more information and full prescribing information, visit www.lomaira.com.

SOURCE KVK Tech, Inc.